Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Esophageal Neoplasms × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 6 Breast Neoplasms 5 Prostatic Neoplasms 4 Lung Neoplasms 3 Stomach Neoplasms 2 Pain 2 Neoplasms 2 Agnosia 2 Supratentorial Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Meningioma 1 Liver Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 Ganglion Cysts 1 Esophageal Neoplasms 1 Emergence Delirium 1 ENT Cancers 1 Cystic Adenomatoid Malformation of Lung, Congenital 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carpal Tunnel Syndrome 1 Cancer Pain 1 Bronchopulmonary Sequestration 1

Interventions

Esophagectomy 9 Radiotherapy 7 Endoscopic Mucosal Resection 7 Enteral Nutrition 6 Endoscopy 6 Standard of Care 5 Magnetic Resonance Spectroscopy 5 Fluorouracil 5 Exercise 5 Cisplatin 5 Surveys and Questionnaires 4 camrelizumab 3 Radiofrequency Ablation 3 Preoperative Exercise 3 Fluorodeoxyglucose F18 3 Blood Specimen Collection 3 spartalizumab 2 Yoga 2 X-Rays 2 Robotic Surgical Procedures 2 Psychosocial Intervention 2 Proton Therapy 2 Practice Guidelines as Topic 2 Palliative Care 2 Paclitaxel 2 Oxaliplatin 2 Octreotide 2 Nutrition Assessment 2 Neoadjuvant Therapy 2 Leucovorin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03185403 2017-06-14

HEMOBLOC

University Hospital, Lille

Phase NA Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡